Bobak R. Azamian - President/CEO and Board Chair, Director at Tarsus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President/CEO and Board Chair, Director
Issuer Symbol
TARS on Nasdaq
All Insider Reports
All Insider Reports

Bobak R. Azamian - trading volume in the past year for Tarsus Pharmaceuticals, Inc.

Holdings reported by Bobak R. Azamian for Tarsus Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 857,991 $71,676,568 $83.54 24 Dec 2025 By the Bobak Azamian Living Trust established April 16, 2018
Restricted Stock Units 60,776 $894,102 $12.89 05 Mar 2026 Direct Common Stock
Common Stock 1,750 $130,917 $74.81 24 Dec 2025 Direct
Stock Option (right to buy) 96,723 05 Mar 2026 Direct Common Stock

Transactions reported by Bobak R. Azamian for Tarsus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.